MAPK3 and melanoma: In vitro and ex vivo angiogenesis assays demonstrated that naringenin induces tumor cell death by decreasing ERK1/2 and JNK MAPK phosphorylation and inhibits angiogenesis in malignant melanoma by suppressing endothelial cell migration, tube formation, and sprouting of microvessels [135].